• Explore /
  • Poster
  • / Digital evaluation of tumor microenvironment immune markers pre- and post-neoadjuvant pembrolizumab in muscle-invasive bladder cancer (Pure-01 trial: An open label, single arm, phase II study).

Digital evaluation of tumor microenvironment immune markers pre- and post-neoadjuvant pembrolizumab in muscle-invasive bladder cancer (Pure-01 trial: An open label, single arm, phase II study).

Abstract Poster

Authors

null

Laura Cattaneo

Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

Laura Cattaneo , Vincenzo Lagano , Laura Carpenito , Caterina Napolitano , Ilaria Bersani , Andrea Necchi , Nicola Nicolai , Biagio Paolini , Maurizio Colecchia , Massimo Milione , Giancarlo Pruneri , Roberta Mortarini , Andrea Anichini , Patrizia Giannatempo

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Prostate Cancer and Urothelial Carcinoma

Track

Urothelial Carcinoma,Prostate Cancer - Advanced

Sub Track

Translational Research, Tumor Biology, Biomarkers, and Pathology

Clinical Trial Registration Number

NCT02736266

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr 541)

DOI

10.1200/JCO.2023.41.6_suppl.541

Abstract #

541

Poster Bd #

M4

Abstract Disclosures

Similar Posters

First Author: Katherine L. Pogue-Geile

First Author: Weihua Guo

First Author: Bahar Saberzadeh Ardestani

First Author: Susanna Swoboda